Bill Murphy retweeted
A new therapy from Christian Capitini, Kyle Wolf, John Kink and Matthew Forsberg could improve supportive care for cancer patients. @WiscPediatrics @UWCarbone @uwsmph @UWMadEngr youtu.be/CqnkBkY6kJw
Bill Murphy retweeted
Clusters of cells that mimic aspects of brain tissue allow researchers to study neurological diseases and test potential treatments. madison.com/news/local/busin…
Bill Murphy retweeted
A @NobelPrize for a Badger 🏅
Congratulations to Francis Halzen, named the 2026 Nobel laureate in physics for his groundbreaking work with @uw_icecube to advance our understanding of neutrinos and the universe’s most energetic events.
news.wisc.edu/university-of-…
Bill Murphy retweeted
We're excited to announce faculty in engineering and in @UWMadison partner schools and colleges as co-leaders of each of our "Engineering Moonshots" -- six ambitious challenges where we aim to deliver meaningful solutions for society. engineering.wisc.edu/news/en… @DeanRanjan
Bill Murphy retweeted
#8 among public universities and #24 for Best Value Schools! These @USNews rankings reflect the incredible breadth and excellence that define @UWMadison. On, Wisconsin! 👐
news.wisc.edu/uw-rises-to-8t…
Bill Murphy retweeted
Read "Planar neural organoids as an advanced in vitro model to study patient-derived melanoma metastasis" from @BillMurphyUW and team in @SciReports:
nature.com/articles/s41598-0…
Bill Murphy retweeted
Two recent studies highlight how human-based models are opening new windows into how cancer spreads.
1⃣ At @wiscorthopedics and @stempharm, Joydeb Majumder, @BillMurphyUW et al. developed hiPSC-derived planar neural organoids to model melanoma brain metastasis using patient-derived melanoma cells. They note that "the results obtained from the orthotopic animal models cannot always be applied to humans due to the interspecies differences."
Their 3D neural tissue model incorporated neural, vascular, and immune components, allowing them to observe how melanoma cells interact with human brain-like tissue, alter neurovascular signaling, trigger inflammatory responses, and respond to therapies. Melanoma growth in the human organoids differed substantially from conventional 2D cultures and showed features more consistent with human cancer biology.
2⃣ At @ColumbiaBME, @ChramiecAlan, @GVNlab et al. created a vascularized multi-organ "metastasis-on-a-chip" platform linking engineered human bone and lung tissues.
Commenting editor Molly Ogle noted: "Preclinical xenograft models fail to fully replicate the human tissue niche to interrogate this process."
This new system enabled them to track circulating breast cancer cells as they crossed blood vessel barriers, colonized specific organs, remodeled their microenvironments, and established premetastatic niches. It also reproduced clinically relevant differences between bone-tropic and lung-tropic cancer cells.
🚀 Platforms like these can help uncover mechanisms that have remained confounded by experiments on animals and provide new opportunities for studying disease biology in humans.
Bill Murphy retweeted
We’re excited to announce a $2.5M NIH Phase II SBIR award to advance our Alzheimer’s drug discovery program using our human neuroimmune organoid platform to identify and advance therapeutics targeting neuroinflammation. Read more: tinyurl.com/2weczz9e
#Alzheimers #organoid
Bill Murphy retweeted
#UWMadison jumped nine spots in @PitchBook's undergraduate entrepreneurship rankings and now ranks No. 6 among U.S. public universities for undergraduate founders.
On, Wisconsin!
news.wisc.edu/uw-madison-ris…
Bill Murphy retweeted
We’ve got another batch of exceptional new faculty joining us this academic year. Among them: Jonathan Soucy, whose research combines stem cell engineering, tissue engineering, and neuroengineering.
engineering.wisc.edu/news/fo…
Bill Murphy retweeted
Good morning, Badgers. We wish you a successful start to your Fall 2026 semester.
Let’s begin.
Bill Murphy retweeted
By recreating early GBM invasion and tumor–immune interactions in a reproducible human model, Stem Pharm’s neuroimmune organoids could support:
💊 Invasion-focused drug screens
🧬 Patient-relevant studies
🔬 Immuno-oncology research
🎯 Personalized therapeutic strategies
Bill Murphy retweeted
Exciting to see Dr. Jeremy Kratz’s team selected for the WARF/MilliporeSigma Non-Animal Drug Testing Challenge - advancing cancer organoid testing with Stem Pharm’s synthetic SP-139 hydrogel combined with Kratz's use of patient-derived plasma. #Organoids #DrugDiscovery #NAMs
Congratulations to the @UWMadison teams selected for the WARF, @MilliporeSigma Challenge Grant!
From organoids to organ-on-chip systems, AI-powered platforms and more, these projects are developing the next generation of drug testing technologies. warf.org/news/advancing-drug…
Bill Murphy retweeted
Why is glioblastoma so difficult to eliminate? GBM cells diffusely infiltrate surrounding brain tissue and can shift between cellular states, helping tumors evade treatment and ultimately recur. Our organoid enables study of this invasive niche in a human multicellular context.
Bill Murphy retweeted
As the NIH and FDA continue advancing human-based New Approach Methodologies (#NAMs), we're excited to contribute models that better capture human biology and help accelerate development of new therapies for Alzheimer's disease.
#Alzheimers #BrainOrganoids #Neuroinflammation
Bill Murphy retweeted
🚨 New publication! 🚨
We're excited to share our latest paper in Cells:
Stimulus-Based ApoE Alzheimer's Disease Induction Model Using Microglia-Containing Brain Organoids for Drug Discovery.
📄 mdpi.com/2073-4409/15/14/126…
🧵👇
Bill Murphy retweeted
GRB Academy and Waunakee Road Warriors Baseball Announce Strategic Partnership...
Read the Full Release HERE: grbacademy.com/grb-announces…
Bill Murphy retweeted
More than 700 people attended the Wisconsin Drives Manufacturing Summit held in the atrium at Lambeau Field in Green Bay, coming together with the goal of propelling Wisconsin to lead the nation in manufacturing.
engineering.wisc.edu/news/a-…
Bill Murphy retweeted
We’re excited to launch our Engineering Moonshots: six bold transdisciplinary efforts that set our direction and concentrate our strengths on the challenges where we can lead—and where engineering can deliver meaningful impact for people and society.
engineering.wisc.edu/blog/si…

















